Another 13K bottles of blood pressure drug recalled
More than 13,000 additional bottles of a popular blood pressure medication have been recalled due to a failed test. The drug in question is chlorthalidone, a diuretic or “water pill” used to treat hypertension and reduce excess fluid caused by heart, kidney or liver disease.
In June, more than 11,000 bottles of chlorthalidone tablets manufactured by India-based Inventia Healthcare Limited were recalled due to “failed dissolution specifications.” This means tablets tested by a regulatory body did not break down correctly, creating a risk of the drug being less effective than intended.
This update includes another 13,567 bottles of the same medication. The dose is 25 mg per tablet, and 100 tablets are packaged inside each bottle. These additional bottles were also recalled due to a failed dissolution test, and Inventia Healthcare Limited is once again the manufacturer. In total, 25,000 bottles of chlorthalidone manufactured by the same company have now been recalled.
As of Sept. 17, the U.S. Food and Drug Administration (FDA) has categorized this incident as a Class II recall. This means using the drug “may cause temporary health consequences, but the probability of a serious health issue is remote.”
Click here for additional details from the FDA.
A recent history of drug recalls
In May, 675 bottles of enalapril maleate tablets manufactured by Unique Pharmaceutical Laboratories and distributed by Rising Pharma Holdings were recalled due to a failed organic impurities test.
In June, Amgen recalled nearly 935,000 bottles of ivabradine, a heart failure drug the company sells under the brand name Corlanor, due to the presence of a foreign substance.
Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.